Form CERTNAS - Certification by the Nasdaq Stock Market approving securities for listing:
SEC Accession No. 9999999997-17-007340
Filing Date
2017-06-29
Accepted
2017-06-30 14:32:03
Documents
1
Effectiveness Date
2017-06-29

Document Format Files

Seq Description Document Type Size
1 AUTO-GENERATED PAPER DOCUMENT 9999999997-17-007340.paper CERTNAS 294
  Scanned paper document scanned.pdf   195837
  Complete submission text file 9999999997-17-007340.txt   1295
Mailing Address 2855 GAZELLE CT CARLSBAD CA 92010
Business Address 55 CAMBRIDGE PARKWAY SUITE 100 CAMBRIDGE MA 02142 760-603-2732
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

EIN.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CERTNAS | Act: 34 | File No.: 001-38137 | Film No.: 17010242
SIC: 2834 Pharmaceutical Preparations